Trial Profile
Prospective Multicenter Cohort Study of Peginterferon, Ribavirin and Telaprevir for Chronic Hepatitis C
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2022
Price :
$35
*
At a glance
- Drugs Peginterferon (Primary) ; Ribavirin (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms SMART-C V2
- 08 Feb 2012 New trial record